Finding lead compounds for dengue antivirals from a collection of old drugs through in silico target prediction and subsequent in vitro validation.
Dengue virus (DENV) infection is one of the most widely spread flavivirus infections. Despite the fatality it could cause, no antiviral treatment is currently available to treat the disease. Hence, this study aimed to repurpose old drugs as novel DENV NS3 inhibitors. Ligand-based (L-B) and proteoche...
Saved in:
Main Authors: | Abdullah, Zafirah Liyana, Chee, Hui-Yee, Yusof, Rohana, Mohd Fauzi, Fazlin |
---|---|
Format: | Article |
Published: |
American Chemical Society (ACS)
2023
|
Online Access: | http://psasir.upm.edu.my/id/eprint/108009/ https://pubs.acs.org/doi/suppl/10.1021/acsomega.3c02607/suppl_file/ao3c02607_si_001.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Revitalizing old drugs: uncovering potential dengue antivirals through in silico target prediction and in vitro validation / Zafirah Liyana Abdullah
by: Abdullah, Zafirah Liyana
Published: (2024) -
Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches
by: Ahammad, Foysal, et al.
Published: (2019) -
In-silico drug target design & its approaches
by: Abduallah Alsafi, Hassen Mohammed, et al.
Published: (2011) -
Inhibition of dengue virus entry into target cells using synthetic antiviral peptides
by: Alhoot, M.A., et al.
Published: (2013) -
Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)